Article
A recently published study supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors.
What determines the optimal urinary diversion?
Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management
Radioligand therapy shows promising safety in patients with mCRPC
Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
Novel drug delivery approach shows promise for UTI
House passes bill that includes 57% budget cut to medical research programs